Global Spinal Fusion Industry is anticipated to witness a 5.4% CAGR, possibly attaining US$ 16,771.8 Million by 2033 | FMI fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.
Ageing Population and Rising Prevalence of Spine Disorders to Drive Spinal Fusion Market to Reach US$ 16,771.8 Million by 2033 at a CAGR of 5.4% fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.
Kuros Biosciences AG: Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-PTH 23.11.2022 / 07:00 CET/CEST First investigational trial of drug-biologic bone graft for spinal fusion No drug-related Serious Adverse Events (SAEs) reporte.